References
- Jagasia MH, Greinix HT, Arora M, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389 e1–401 e1.
- Parker P, Chao NJ, Ben-Ezra J, et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine. 1996;75(5):279–285.
- Couriel DR, Beguelin GZ, Giralt S, et al. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant. 2002;30(8):543–546.
- Saw JL, Sidiqi MH, Mauermann ML, et al. Immune-mediated neuromuscular complications of graft-versus-host disease. Muscle Nerve. 2021;63(6):852–860.
- Fleming JN, Shulman HM, Nash RA, et al. Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis. PLoS One. 2009;4(7):e6203.
- Kuzmina Z, Gounden V, Curtis L, et al. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria. Am J Hematol. 2015;90(2):114–119.
- Grauer O, Wolff D, Bertz H, et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft-versus-host disease. Brain. 2010;133(10):2852–2865.
- Smith CI, Hammarstrom L, Lefvert AK. Bone-marrow grafting induces acetylcholine receptor antibody formation. Lancet. 1985;1(8435):978.
- Li Z, Rubinstein SM, Thota R, et al. Immune-mediated complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016;22(8):1368–1375.
- Stevens AM, Sullivan KM, Nelson JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology. 2003;42(1):34–39.
- Raphalen JH, Louis SL, Regis PL, et al. Myopathie inflammatoire après allogreffe de moelle osseuse: à propos de 12 cas. Rev Med Intern. 2018;39:A114–A115.
- Oda K, Nakaseko C, Ozawa S, et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant. 2009;43(2):159–167.
- Stephenson AL, Mackenzie IR, Levy RD, et al. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax. 2001;56(1):82–84.
- Leano AM, Miller K, White AC. Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant. Bone Marrow Transplant. 2000;26(10):1117–1120.
- Zeiser R, von Bubnoff N, Butler J, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800–1810.